MEDVi, a telehealth service focused on weight‑management, announced a new entry‑level price for its GLP‑1 weight‑loss program. Eligible patients can begin treatment with compounded semaglutide for just $179 for the first month, a price that undercuts many brand‑name cash options.
How the program works
Patients sign up online, complete a health questionnaire, and are matched with a licensed medical provider. After a virtual consultation, the provider may prescribe a personalized plan that can include semaglutide, tirzepatide, or other branded GLP‑1 medications. The platform does not require insurance, and medication is shipped directly to the patient’s home.
Potential results and support
According to MEDVi, participants who follow the provider‑guided plan may lose up to 20% of their body weight. In addition to medication, the service offers a nutrition component called MEDVi Meals, a meal‑delivery program designed to reinforce healthy eating habits throughout the weight‑loss journey.
Why the lower price matters
GLP‑1 drugs such as semaglutide and tirzepatide have become popular prescription options for medically supervised weight loss, but brand‑name versions often carry a high cash price. By using compounded formulations, MEDVi aims to make these treatments more accessible to patients who prioritize cost and convenience.
Safety and medical oversight
All GLP‑1 medications listed on the MEDVi website include safety information and potential side effects. The company advises patients to consult their own physician or another qualified health professional before starting, stopping, or changing any medication regimen.
Considerations for prospective users
MEDVi may appeal to individuals comfortable with compounded medications and who value the convenience of online consultations and home delivery. The program’s affordability, combined with ongoing provider support, offers a relatively accessible path to medically supervised weight loss.
Readers should note that pricing and availability are subject to change, and the introductory $179 rate applies only to the first month of treatment. Ongoing costs will depend on the specific medication, dosage, and any additional services selected.
Original reporting: Las Cruces Sun News (HLL/CB) — read the source article.
